Cancer Treatment Patterns and Factors Affecting Receipt of Treatment in Older Adults: Results from the ASPREE Cancer Treatment Substudy (ACTS)
Authors:
- Jaidyn MuhandiramgeJMJaidyn Muhandiramge
- Erica T. WarnerEWErica T. Warner
- John R. ZalcbergJZJohn R. Zalcberg
- Andrew HaydonAHAndrew Haydon
- Galina PolekhinaGPGalina Polekhina
- Gijsberta J. van LondenGLGijsberta J. van Londen
- Peter GibbsPGPeter Gibbs
- Wendy B. BernsteinWBWendy B. Bernstein
- Jeanne TieJTJeanne Tie
- Jeremy L. MillarJMJeremy L. Millar
- Victoria J. MarVMVictoria J. Mar
- John J. McNeilJMJohn J. McNeil
Open Access
Abstract
Introduction: Cancer treatment planning in older adults is complex and requires careful balancing of survival, quality of life benefits, and risk of treatment-related morbidity and toxicity. As a result, treatment selection in this cohort tends to differ from that for younger patients. However, there are very few studies describing cancer treatment patterns in older cohorts. Methods: We used data from the ASPirin in Reducing Events in the Elderly (ASPREE) trial and the ASPREE Cancer Treatment Substudy (ACTS) to describe cancer treatment patterns in older adults. We used a multivariate logistic regression model to identify factors affecting receipt of treatment. Results: Of 1893 eligible Australian and United States (US) participants with incident cancer, 1569 (81%) received some form of cancer treatment. Non-metastatic breast cancers most frequently received treatment (98%), while haematological malignancy received the lowest rates of treatment (60%). Factors associated with not receiving treatment were older age (OR 0.94, 95% CI 0.91–0.96), residence in the US (OR 0.34, 95% CI 0.22–0.54), smoking (OR 0.57, 95% CI 0.40–0.81), and diabetes (OR 0.56, 95% CI 0.39–0.80). After adjustment for treatment patterns in sex-specific cancers, sex did not impact receipt of treatment. Conclusions: This study is one of the first describing cancer treatment patterns and factors affecting receipt of treatment across common cancer types in older adults. We found that most older adults with cancer received some form of cancer treatment, typically surgery or systemic therapy, although this varied by factors such as cancer type, age, sex, and country of residence.Keywords
All Related Versions
Funding Information
- National Institutes of Health (P30 CA047904, U01 AG029824, U19 AG062682, 3U19 AG062682-02S1, 334047, 1127060)
- National Health and Medical Research Council of Australia (P30 CA047904, U01 AG029824, U19 AG062682, 3U19 AG062682-02S1, 334047, 1127060)
- Monash University (P30 CA047904, U01 AG029824, U19 AG062682, 3U19 AG062682-02S1, 334047, 1127060)
- Victorian Cancer Agency (P30 CA047904, U01 AG029824, U19 AG062682, 3U19 AG062682-02S1, 334047, 1127060)
This publication has 48 references indexed in Scilit:
- Study design of ASPirin in Reducing Events in the Elderly (ASPREE): A randomized, controlled trialContemporary Clinical Trials, 2013
- American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for OncologyJournal of Clinical Oncology, 2012
- Frailty in the older surgical patient: a reviewAge and Ageing, 2012
- The Effect of Cigarette Smoking on Cancer Treatment–Related Side EffectsThe Oncologist, 2011
- The Attributable Risk of Smoking on Surgical ComplicationsAnnals of Surgery, 2011
- Impact of Comorbidity on Chemotherapy Use and Outcomes in Solid Tumors: A Systematic ReviewJournal of Clinical Oncology, 2011
- Older adults and cancer treatmentCancer, 2008
- The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancerProstate Cancer and Prostatic Diseases, 2005
- Trends in the Treatment of Acute Myeloid Leukaemia in the ElderlyDrugs & Aging, 2005
- Racial and Ethnic Disparities in the Receipt of Cancer TreatmentJNCI: Journal of the National Cancer Institute, 2002